CADENCE COMPLETES ACQUISITION OF INTRAVENOUS ACETAMINOPHEN RIGHTS

Cadence Pharmaceuticals Inc. announced Thursday that it has completed its acquisition of the rights to an intravenous formulation of acetaminophen, IV APAP.

San Diego Source (http://www.sddt.com/News/article.cfm?SourceCode=20060330tqc)